Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer

To avoid improper tumor volume contouring in radiation therapy (RT) and other invasive procedures, we report a case of uterine adenomyosis showing increased (18)F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)/computed tomography (CT) mimicking malignant tumor in a 44-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jeong Il, Huh, Seung Jae, Kim, Young Il, Kim, Tae-Joong, Park, Byung Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429905/
https://www.ncbi.nlm.nih.gov/pubmed/22984673
http://dx.doi.org/10.3857/roj.2011.29.3.214
Descripción
Sumario:To avoid improper tumor volume contouring in radiation therapy (RT) and other invasive procedures, we report a case of uterine adenomyosis showing increased (18)F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)/computed tomography (CT) mimicking malignant tumor in a 44-year-old woman during concurrent chemoradiation therapy (CCRT) for uterine cervical cancer. The adenomyosis was not associated with her menstrual cycle or with normal endometrium uptake, and it resolved one month after completion of RT. This case indicates that uterine adenomyosis in a premenopausal woman may show false positive uptake of (18)FDG-PET/CT associated with CCRT.

Ejemplares similares